🔗 Share this article

An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a flourishing market exists on Telegram, where communities with numerous of participants share comparison images, injection guides and assertions of next-day UK delivery. Sellers promote the drug there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Voice Worries

However, physicians and chemists have warned that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting products of unknown origin.

Some professionals said the demand for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Material Removal

Based on TikTok, the platform has taken down violative content and prohibited related hashtags and search suggestions. The organization stated it was dedicated to keeping the platform safe and allocating resources in enhancing enforcement strategies.

Digital Marketplace Operations

Investigations also found groups with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of slimming results, glowing reviews and detailed guides for mixing or administering at home.

After minutes of joining one community, a seller shared WhatsApp details, where the majority of purchases take place. The vendor sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Product Details and Costs

Inside these communities, messages show dark colored parcels with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When questioned how long a injector should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service stated it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they cannot confirm. Although the science behind retatrutide is sound, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her team has already seen patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly significant medical dangers”.